• Olsalazine Sodium: Anti-Inflammatory Mechanisms & Research U

  2026-08-06

  Olsalazine Sodium, a mesalamine dimer, is a potent anti-inflammatory prodrug and LTB4 chemotaxis inhibitor. It is widely used in colorectal cancer tumor models and xenobiotic transport studies. Its robust efficacy and distinct molecular profile make it valuable for cancer and inflammation research.

• 2-Thio-dCTP for Site-Specific DNA Modification & Polymerase

  2026-08-06

  2-Thio-dCTP empowers researchers to achieve precise, site-specific DNA modification and high-fidelity enzymatic assays by leveraging its unique sulfur-substituted cytosine base. Its integration enables robust DNA polymerase substrate studies and advances chromatin regulation research, especially in workflows examining mitotic fidelity and DNA-protein interactions.

• Honokiol: Redefining NF-κB Inhibition in Translational Oncol

  2026-08-05

  Explore how Honokiol—2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol—unlocks new precision for translational cancer researchers via targeted NF-κB pathway inhibition, robust antioxidant activity, and advanced in vitro validation strategies.

• β-Elemene Suppresses Adipogenesis via AMPK Activation in 3T3

  2026-08-05

  This study elucidates how β-elemene inhibits adipogenesis and reverses insulin resistance in 3T3-L1 adipocytes by activating the AMPK pathway. The findings provide a mechanistic basis for β-elemene’s potential as a molecular tool in obesity and metabolic research.

• CX-5461 Induces Mitotic Catastrophe and Sensitizes Cervical

  2026-08-04

  This study demonstrates that the RNA polymerase I inhibitor CX-5461 potently suppresses cervical cancer cell growth by inducing DNA damage, activating the ATM/ATR pathway, and triggering mitotic catastrophe. It also shows that CX-5461 enhances cisplatin sensitivity, supporting its therapeutic potential for chemoresistant cervical cancer.

• (-)-Arctigenin as a Precision MEK1 Inhibitor in Cancer Workf

  2026-08-04

  (-)-Arctigenin empowers translational researchers with unparalleled mechanistic precision as both a MEK1 inhibitor and anti-inflammatory agent, uniquely supporting studies on tumor microenvironment crosstalk and NF-κB signaling. This guide delivers actionable workflow enhancements, troubleshooting strategies, and protocol-level insights to maximize the impact of APExBIO’s Arctigenin in bench-to-bedside oncology and immunology research.

• PrLGlu/avBNSTGABA Circuit Rapidly Modulates Depression in Mi

  2026-08-03

  This study identifies the glutamatergic prelimbic to GABAergic anterior ventral BNST (PrLGlu/avBNSTGABA) circuit as a rapid modulator of depression-like behaviors in male mice. Using chemogenetic and optogenetic approaches, the work shows targeted activation of this pathway produces swift antidepressant effects, with significant implications for understanding and treating depression.

• Protein A/G Magnetic Beads: Technical Guidance for Antibody

  2026-08-03

  Protein A/G Magnetic Beads (SKU K1305) address common challenges in antibody purification and protein-protein interaction workflows by providing high specificity and reduced background binding. Designed for applications such as immunoprecipitation, co-IP, and Ch-IP, these beads are not intended for diagnostic or clinical use and should be avoided in workflows requiring non-IgG antibody capture.

• 3-Aminobenzamide (PARP-IN-1): Transforming PARP Inhibition W

  2026-08-02

  3-Aminobenzamide (PARP-IN-1) unlocks precision in poly (ADP-ribose) polymerase inhibition, enabling robust, reproducible results for oxidative stress, endothelial function, and diabetic nephropathy models. Its proven IC50 and workflow adaptability set a new benchmark for applied research and troubleshooting. Discover how APExBIO’s offering empowers advanced experimental designs and cross-domain innovation.

• Antiseptics for Burns: Efficacy, Limitations, and Research I

  2026-08-01

  This Cochrane review systematically evaluated the comparative effects of antiseptics—including topical antibiotics—on burn wound healing, infection rates, and adverse events. The findings highlight the nuanced efficacy of silver-based dressings versus antibiotic therapies, underscoring the need for evidence-based selection of antimicrobial strategies in burn care and infection research models.

• IPA-3: Unraveling Pak1 Autoinhibition for Advanced Neuroinfl

  2026-07-31

  Explore how IPA-3, a selective Pak1 inhibitor, enables precise manipulation of kinase signaling in neuroinflammation and cancer biology research. This article offers a mechanistic deep dive, recent reference insights, and advanced protocol guidance distinct from standard workflows.

• Annexin V-PE Apoptosis Detection Kit: Rapid, Live-Cell Assay

  2026-07-31

  The Annexin V-PE Apoptosis Detection Kit from APExBIO empowers researchers with fast, fixation-free apoptosis detection directly in live cells. Its one-step protocol and high sensitivity make it a top choice for dissecting cell death pathways and evaluating therapeutic interventions in translational studies.

• Berberine Targets RXRα/PPARγ/NEDD4 to Limit SASP in Atherosc

  2026-07-30

  This study reveals that berberine suppresses senescence-associated secretory phenotype (SASP)–driven inflammation in atherosclerosis by modulating the RXRα/PPARγ/NEDD4 pathway in macrophage-derived foam cells. Mechanistic insights highlight the regulation of ubiquitination and transcriptional activity, providing novel targets for addressing chronic vascular inflammation and cellular senescence.

• UK-5099 in Immune Metabolism: Beyond Protocols to Mechanisti

  2026-07-30

  Explore how UK-5099 (PF-1005023) advances mitochondrial metabolism research and immune assay innovation. This in-depth analysis reveals mechanistic insights and practical strategies for leveraging UK-5099 in cutting-edge immunometabolic studies.

• Deferasirox Fe3+ Chelate: Optimizing Iron Overload Research

  2026-07-29

  Deferasirox Fe3+ chelate (Exjade) enables precise modeling of iron overload and chelation in chronic anemia and beta-thalassemia studies. This guide delivers actionable protocol enhancements, troubleshooting strategies, and advanced use-cases to maximize research impact using APExBIO’s high-purity reagent.

15935 records 1/1063 page Next 12345 下5页 Last page